Literature DB >> 29989851

Saturated fatty acid combined with lipopolysaccharide stimulates a strong inflammatory response in hepatocytes in vivo and in vitro.

Yanchun Li1, Zhongyang Lu2, Ji Hyun Ru1, Maria F Lopes-Virella1,2, Timothy J Lyons1, Yan Huang1,2.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease and consumption of high-fat diet (HFD) is a risk factor for NAFLD. The HFD not only increases intake of saturated fatty acid (SFA) but also induces metabolic endotoxemia, an HFD-associated increase in circulating lipopolysaccharide (LPS). Although it is known that SFA or LPS promote hepatic inflammation, a hallmark of NAFLD, it remains unclear how SFA in combination with LPS stimulates host inflammatory response in hepatocytes. In this study, we performed both in vivo and in vitro experiments to investigate the effect of SFA in combination with LPS on proinflammatory gene expression in hepatocytes. Our animal study showed that feeding low-density lipoprotein-deficient mice HFD enriched with SFA and injection of low-dose LPS cooperatively stimulated IL-6 expression in livers. To understand how SFA and LPS interact to promote IL-6 expression, our in vitro studies showed that palmitic acid (PA), a major SFA, and LPS exerted synergistic effect on the expression of IL-6 in hepatocytes. Furthermore, coculture of hepatocytes with macrophages resulted in a greater IL-6 expression than culture of hepatocytes without macrophages in response to the combination of PA and LPS. Finally, we observed that LPS and PA increased ceramide production by cooperatively stimulating ceramide de novo synthesis, which played an essential role in the synergistic stimulation of proinflammatory gene expression by LPS and PA. Taken together, this study showed that SFA in combination with LPS stimulated a strong inflammatory response in hepatocytes in vivo and in vitro.

Entities:  

Keywords:  ceramide; fatty acid; hepatocyte; inflammation; lipopolysaccharide

Mesh:

Substances:

Year:  2018        PMID: 29989851      PMCID: PMC6293169          DOI: 10.1152/ajpendo.00015.2018

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  57 in total

Review 1.  TLR4 as the mammalian endotoxin sensor.

Authors:  B Beutler
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

2.  The alternative pathway is critical for pathogenic complement activation in endotoxin- and diet-induced atherosclerosis in low-density lipoprotein receptor-deficient mice.

Authors:  Talat H Malik; Andrea Cortini; Daniele Carassiti; Joseph J Boyle; Dorian O Haskard; Marina Botto
Journal:  Circulation       Date:  2010-10-25       Impact factor: 29.690

Review 3.  Non-alcoholic fatty liver disease and increased risk of cardiovascular disease.

Authors:  Giovanni Targher; Guido Arcaro
Journal:  Atherosclerosis       Date:  2006-09-12       Impact factor: 5.162

4.  Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice.

Authors:  Mohammad Reza Hojjati; Zhiqiang Li; Hongwen Zhou; Songshan Tang; Chongmin Huan; Everlyn Ooi; Shendi Lu; Xian-Cheng Jiang
Journal:  J Biol Chem       Date:  2004-12-06       Impact factor: 5.157

5.  MicroRNA 375 mediates palmitate-induced enteric neuronal damage and high-fat diet-induced delayed intestinal transit in mice.

Authors:  Behtash Ghazi Nezami; Simon M Mwangi; Jai Eun Lee; Sabrina Jeppsson; Mallappa Anitha; Shadi S Yarandi; Alton B Farris; Shanthi Srinivasan
Journal:  Gastroenterology       Date:  2013-10-25       Impact factor: 22.682

Review 6.  Inflammation, stress, and diabetes.

Authors:  Kathryn E Wellen; Gökhan S Hotamisligil
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

Review 7.  From fat to FAT (CD36/SR-B2): Understanding the regulation of cellular fatty acid uptake.

Authors:  Jan F C Glatz; Joost J F P Luiken
Journal:  Biochimie       Date:  2016-12-22       Impact factor: 4.079

Review 8.  Non-alcoholic fatty liver disease.

Authors:  Briohny W Smith; Leon A Adams
Journal:  Crit Rev Clin Lab Sci       Date:  2011 May-Jun       Impact factor: 6.250

Review 9.  Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease.

Authors:  Alexandra K Leamy; Robert A Egnatchik; Jamey D Young
Journal:  Prog Lipid Res       Date:  2012-11-23       Impact factor: 16.195

Review 10.  Innate Immunity and Inflammation in NAFLD/NASH.

Authors:  Marco Arrese; Daniel Cabrera; Alexis M Kalergis; Ariel E Feldstein
Journal:  Dig Dis Sci       Date:  2016-02-03       Impact factor: 3.199

View more
  8 in total

Review 1.  The Impact of Diet on Bone and Fracture Risk in Diabetes.

Authors:  M Faraj; N Napoli
Journal:  Curr Osteoporos Rep       Date:  2022-02-24       Impact factor: 5.096

2.  Cellular and molecular effects of silymarin on the transdifferentiation processes of LX-2 cells and its connection with lipid metabolism.

Authors:  Caio Mateus Silva; Gustavo Duarte Ferrari; Luciane Carla Alberici; Osmar Malaspina; Karen C M Moraes
Journal:  Mol Cell Biochem       Date:  2020-03-17       Impact factor: 3.396

3.  Amitriptyline inhibits nonalcoholic steatohepatitis and atherosclerosis induced by high-fat diet and LPS through modulation of sphingolipid metabolism.

Authors:  Zhongyang Lu; Yanchun Li; Wing-Kin Syn; Zhewu Wang; Maria F Lopes-Virella; Timothy J Lyons; Yan Huang
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-12-10       Impact factor: 4.310

4.  TLCD1 and TLCD2 regulate cellular phosphatidylethanolamine composition and promote the progression of non-alcoholic steatohepatitis.

Authors:  Kasparas Petkevicius; Henrik Palmgren; Matthew S Glover; Andrea Ahnmark; Anne-Christine Andréasson; Katja Madeyski-Bengtson; Hiroki Kawana; Erik L Allman; Delaney Kaper; Martin Uhrbom; Liselotte Andersson; Leif Aasehaug; Johan Forsström; Simonetta Wallin; Ingela Ahlstedt; Renata Leke; Daniel Karlsson; Hernán González-King; Lars Löfgren; Ralf Nilsson; Giovanni Pellegrini; Nozomu Kono; Junken Aoki; Sonja Hess; Grzegorz Sienski; Marc Pilon; Mohammad Bohlooly-Y; Marcello Maresca; Xiao-Rong Peng
Journal:  Nat Commun       Date:  2022-10-14       Impact factor: 17.694

5.  Orotic acid-treated hepatocellular carcinoma cells resist steatosis by modification of fatty acid metabolism.

Authors:  Johanna Matilainen; Anne-Mari Mustonen; Kirsi Rilla; Reijo Käkelä; Sanna P Sihvo; Petteri Nieminen
Journal:  Lipids Health Dis       Date:  2020-04-13       Impact factor: 3.876

6.  Berberine inhibits free fatty acid and LPS-induced inflammation via modulating ER stress response in macrophages and hepatocytes.

Authors:  Yanyan Wang; Xiqiao Zhou; Derrick Zhao; Xuan Wang; Emily C Gurley; Runping Liu; Xiaojiaoyang Li; Phillip B Hylemon; Weidong Chen; Huiping Zhou
Journal:  PLoS One       Date:  2020-05-01       Impact factor: 3.752

7.  Candida Administration Worsens Cecal Ligation and Puncture-Induced Sepsis in Obese Mice Through Gut Dysbiosis Enhanced Systemic Inflammation, Impact of Pathogen-Associated Molecules From Gut Translocation and Saturated Fatty Acid.

Authors:  Wimonrat Panpetch; Vorthon Sawaswong; Prangwalai Chanchaem; Thunnicha Ondee; Cong Phi Dang; Sunchai Payungporn; Asada Leelahavanichkul
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

8.  Role of HO-1 against Saturated Fatty Acid-Induced Oxidative Stress in Hepatocytes.

Authors:  Noriyoshi Ogino; Koichiro Miyagawa; Kenjiro Nagaoka; Yuki Matsuura-Harada; Shihona Ogino; Masashi Kusanaga; Shinji Oe; Yuichi Honma; Masaru Harada; Masamitsu Eitoku; Narufumi Suganuma; Keiki Ogino
Journal:  Nutrients       Date:  2021-03-19       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.